Discontinuation of Dasatinib in Patients With Chronic Myeloid Leukemia-CP Who Have Maintained Complete Molecular Remission for Two Years; Dasatinib Stop Trial
Clinical trial NCT01627132 · UNKNOWN
Trial details
- NCT number
- NCT01627132
- Sponsor
- Shimousa Hematology Study Group
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-02-01
- Primary completion
- 2017-02-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.